Publication: Antiphospholipid antibodies negativization: time for testing for non-criteria aPL?
Loading...
Identifiers
Date
2017-04-26
Authors
Radin, M
Cecchi, I
Perez-Sanchez, C
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Sage Publications
Abstract
Sir,While we read with interest the recent article byComarmond and colleagues 1 about the cessation oforal anticoagulants in antiphospholipid syndrome(APS), we do feel there are some points of the studystill open for discussion.Comarmond and colleagues 1 describe 10 patientswith prolonged disappearance of antiphospholipidantibodies (aPL) that were stopped anticoagulationtherapy. After a median duration of follow-up of 19months since the cessation of oral anticoagulants,one out of 10 patients relapsed developing pulmon-ary embolism.
Description
MeSH Terms
Antibodies, antiphospholipid
Anticoagulants
Antiphospholipid syndrome
Humans
Lupus erythematosus, systemic
Anticoagulants
Antiphospholipid syndrome
Humans
Lupus erythematosus, systemic
DeCS Terms
Anticoagulantes
Anticuerpos antifosfolípidos
Lupus eritematoso sistémico
Síndrome antifosfolípido
Anticuerpos antifosfolípidos
Lupus eritematoso sistémico
Síndrome antifosfolípido
CIE Terms
Keywords
Anticoagulants, Follow-up studies, Embolism
Citation
Radin M, Cecchi I, Pérez-Sánchez C. Antiphospholipid antibodies negativization: time for testing for non-criteria aPL? Lupus. 2017 Nov;26(13):1457-1458